VR Adviser »

Aeglea Biotherapeutics shares owned by VR Adviser

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by VR Adviser from 13F filings

Historical chart of VR Adviser investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by VR Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by VR Adviser

Quarter filed Position value Share count Share price at filing
2023-12-31 $51M 2.4M 21.52